Xiao-Zhong Peng (Xiaozhong Peng, Hongqi Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Venues

Signal transduction and targeted therapy

Proceedings of the National Academy of Sciences of the United States of America

Nature

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Guo, Pan Xiang, Xiaojiao Sun, Wei Liu, Jiafeng Zhou, Bin Yin, Lin Hou, Boqin Qiang, Huiliang Li, Pengcheng Shu, Xiao-Zhong Peng
Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy. Signal transduction and targeted therapy 9 (1) (2024)
Yan Guo, Pan Xiang, Xiaojiao Sun, Wei Liu, Jiafeng Zhou, Bin Yin, Lin Hou, Boqin Qiang, Huiliang Li, Pengcheng Shu, Xiao-Zhong Peng
Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy. Signal transduction and targeted therapy 9 (1) (2024)
Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zi-Lei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Gan Wang, Xiao-Zhong Peng, Shuo Yang, Jingwen Xu, Dawit Adisu Tadese, James Mwangi, Peter Muiruri Kamau, Zhiye Zhang, Lian Yang, Guoyang Liao, Xudong Zhao, Xiaozhong Peng, Ren Lai
Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zi-Lei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Gan Wang, Xiao-Zhong Peng, Shuo Yang, Jingwen Xu, Dawit Adisu Tadese, James Mwangi, Peter Muiruri Kamau, Zhiye Zhang, Lian Yang, Guoyang Liao, Xudong Zhao, Xiaozhong Peng, Ren Lai
Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zi-Lei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Gan Wang, Xiao-Zhong Peng, Shuo Yang, Jingwen Xu, Dawit Adisu Tadese, James Mwangi, Peter Muiruri Kamau, Zhiye Zhang, Lian Yang, Guoyang Liao, Xudong Zhao, Xiaozhong Peng, Ren Lai
Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Yan Guo, Pan Xiang, Xiaojiao Sun, Wei Liu, Jiafeng Zhou, Bin Yin, Lin Hou, Boqin Qiang, Huiliang Li, Pengcheng Shu, Xiao-Zhong Peng
Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy. Signal transduction and targeted therapy 9 (1) (2024)
Yan Guo, Pan Xiang, Xiaojiao Sun, Wei Liu, Jiafeng Zhou, Bin Yin, Lin Hou, Boqin Qiang, Huiliang Li, Pengcheng Shu, Xiao-Zhong Peng
Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy. Signal transduction and targeted therapy 9 (1) (2024)
Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zi-Lei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Gan Wang, Xiao-Zhong Peng, Shuo Yang, Jingwen Xu, Dawit Adisu Tadese, James Mwangi, Peter Muiruri Kamau, Zhiye Zhang, Lian Yang, Guoyang Liao, Xudong Zhao, Xiaozhong Peng, Ren Lai
Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Zhiyi Liao, Chaoming Wang, Xiaopeng Tang, Mengli Yang, Zi-Lei Duan, Lei Liu, Shuaiyao Lu, Lei Ma, Ruomei Cheng, Gan Wang, Xiao-Zhong Peng, Shuo Yang, Jingwen Xu, Dawit Adisu Tadese, James Mwangi, Peter Muiruri Kamau, Zhiye Zhang, Lian Yang, Guoyang Liao, Xudong Zhao, Xiaozhong Peng, Ren Lai
Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Jiaorong Qu, Bojun Qiu, Yuxin Zhang, Yan Hu, Zhixing Wang, Zhiang Guan, Yiming Qin, Tongtong Sui, Fan Wu, Boyang Li, Wei Han, Xiao-Zhong Peng
The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling. Signal transduction and targeted therapy 8 (1) (2023)
Jiang-Feng Liu, Ya-Nan Zhou, Shuai-Yao Lu, Ye-Hong Yang, Song-Feng Wu, De-Pei Liu, Xiao-Zhong Peng, Jun-Tao Yang
Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques. Signal transduction and targeted therapy 7 (1) (2022)
Tianhong Xie, Shuai-Yao Lu, Zhanlong He, Hongqi Liu, Junbin Wang, Cong Tang, Ting Yang, Wenhai Yu, Hua Li, Yun Yang, Hao Yang, Lei Yue, Yanan Zhou, Fengmei Yang, Zhiwu Luo, Yanyan Li, Hong Xiang, Yuan Zhao, Jie Wang, Haixuan Wang, Runxiang Long, Dexuan Kuang, Wenjie Tan, Xiao-Zhong Peng, Qihan Li, Zhongping Xie
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern. Signal transduction and targeted therapy 7 (1) (2022)
Meihui Cheng, Jingwen Xu, Kaiyun Ding, Jing Zhang, Wei Lu, Jiansheng Liu, Jiahong Gao, Kishore R Alugupalli, Xiao-Zhong Peng
Attenuation of relapsing fever neuroborreliosis in mice by IL-17A blockade. Proceedings of the National Academy of Sciences of the United States of America 119 (42) (2022)
Qian He, Qunying Mao, Xiao-Zhong Peng, Zhanlong He, Shuai-Yao Lu, Jialu Zhang, Fan Gao, Lianlian Bian, Chaoqiang An, Wenhai Yu, Fengmei Yang, Yanan Zhou, Yun Yang, Yanyan Li, Yadi Yuan, Xujia Yan, Jinghuan Yang, Xing Wu, Wei Jin Huang, Changgui Li, Junzhi Wang, Zhenglun Liang, Miao Xu
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates. Signal transduction and targeted therapy 7 (1) (2022)
Zhenfei Bi, Weiqi Hong, Haiying Que, Cai He, Wenyan Ren, Jingyun Yang, Tianqi Lu, Li Chen, Shuai-Yao Lu, Xiao-Zhong Peng, Yanping Qian
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice. Signal transduction and targeted therapy 6 (1) (2021)
Ren Yang, Yao Deng, Baoying Huang, Lei Huang, Ang Lin, Yuhua Li, Wenling Wang, Jingjing Liu, Shuaiyao Lu, Zhenzhen Zhan, Yufei Wang, Ruhan A, Wen Wang, Peihua Niu, Li Zhao, Shiqiang Li, Xiaopin Ma, Luyao Zhang, Yujian Zhang, Weiguo Yao, Xingjie Liang, Jin-Cun Zhao, Zhongmin Liu, Xiao-Zhong Peng, Hangwen Li, Wenjie Tan
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Signal transduction and targeted therapy 6 (1) (2021)
Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuai-Yao Lu, Xiao-Zhong Peng
Neurological complications and infection mechanism of SARS-COV-2. Signal transduction and targeted therapy 6 (1) (2021)
Weiqi Hong, Jingyun Yang, Zhenfei Bi, Cai He, Hong Lei, Wenhai Yu, Yun Yang, Changfa Fan, Shuaiyao Lu, Xiao-Zhong Peng, Yanping Qian
A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome. Signal transduction and targeted therapy 6 (1) (2021)
Li Jiao, Yun Yang, Wenhai Yu, Yuan Zhao, Haiting Long, Jiahong Gao, Kaiyun Ding, Chunxia Ma, Jingmei Li, Siwen Zhao, Haixuan Wang, Haiyan Li, Mengli Yang, Jingwen Xu, Junbin Wang, Jing Yang, Dexuan Kuang, Fangyu Luo, Xingli Qian, Longjiang Xu, Bin Yin, Wei Liu, Hongqi Liu, Shuaiyao Lu, Xiao-Zhong Peng
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal transduction and targeted therapy 6 (1) (2021)
Linlin Bao, Wei Deng, Baoying Huang, Hong Gao, Jiangning Liu, Lili Ren, Qiang Wei, Pin Yu, Yanfeng Xu, Feifei Qi, Yajin Qu, Fengdi Li, Qi Lv, Wenling Wang, Jing Xue, Shuran Gong, Mingya Liu, Guanpeng Wang, Shunyi Wang, Zhiqi Song, Linna Zhao, Peipei Liu, Li Zhao, Fei Ye, Huijuan Wang, Weimin Zhou, Na Zhu, Wei Zhen, Haisheng Yu, Xiaojuan Zhang, Li Guo, Lan Chen, Conghui Wang, Ying Wang, Xinming Wang, Yan Xiao, Qiangming Sun, Xiao-Zhong Peng, Fanli Zhu, Chunxia Ma, Lingmei Yan, Mengli Yang, Jun Han, Wenbo Xu, Wenjie Tan, Xiaozhong Peng, Qi Jin, Guizhen Wu, Chuan Qin
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583 (7818) (2020)
Jingyun Yang, Wei Wang, Zimin Chen, Shuaiyao Lu, Fanli Yang, Zhenfei Bi, Linlin Bao, Fei Mo, Xue Li, Yong Huang, Weiqi Hong, Yun Yang, Yuan Zhao, Fei Ye, Sheng Lin, Wei Deng, Hua Chen, Hong Lei, Ziqi Zhang, Min Luo, Hong Gao, Yue Zheng, Yanqiu Gong, Xiaohua Jiang, Yanfeng Xu, Qi Lv, Dan Li, Manni Wang, Fengdi Li, Shunyi Wang, Guanpeng Wang, Pin Yu, Yajin Qu, Li Yang, Hongxin Deng, Aiping Tong, Jiong Li, Zhenling Wang, Jinliang Yang, Guobo Shen, Zhiwei Zhao, Yuhua Li, Jingwen Luo, Xiao-Zhong Peng, Wenhai Yu, Mengli Yang, Jingwen Xu, Junbin Wang, Haiyan Li, Haixuan Wang, Dexuan Kuang, Panpan Lin, Zhengtao Hu, Wei Guo, Wei Cheng, Yanlin He, Xiangrong Song, Chong Chen, Zhihong Xue, Shaohua Yao, Lu Chen, Xuelei Ma, Siyuan Chen, Maling Gou, Wei Jin Huang, You-Chun Wang, Changfa Fan, Zhixin Tian, Ming Shi, Fu-Sheng Wang, Lunzhi Dai, Mingshan Jiang, Gen Li, Guangyu Wang, Yong Peng, Zhiyong Qian, Canhua Huang, Johnson Yiu-Nam Lau, Zhenglin Yang, Yuquan Wei, Xiaobo Cen, Xiaozhong Peng, Chuan Qin, Kang Zhang, Guang-Wen Lu, Yanping Qian
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586 (7830) (2020)

Xiao-Zhong Peng.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaozhong Peng, Hongqi Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Zhong Peng (Xiaozhong Peng, Hongqi Liu)